TGA Regulatory Strategy & Pathway Planning
Entering the Australian market requires choosing the right TGA registration pathway for your product category, risk classification and existing overseas approvals. We define that pathway early — saving time, cost and the risk of a misdirected submission.
- Product category and registration pathway determination
- Prescription, OTC, complementary and device routes
- Leveraging overseas approvals (FDA, EMA) for TGA registration
- Target evidence profile and dossier gap analysis
- Multi-jurisdictional strategy (TGA + FDA/EMA)


